-
(单词翻译:双击或拖选)
Corporate1 payouts in the opioid crisis are being finalized2
Companies embroiled4 in the opioid crisis are finalizing5 mega-settlements. They are expected to pay more than $30 billion to settle claims that they fueled the deadly addiction6 epidemic7.
RACHEL MARTIN, HOST:
Over the past two decades, the opioid crisis has been linked to more than 500,000 deaths in the U.S. And soon final settlements are expected with some of the biggest corporations accused of fueling the problem. Those settlements are expected to be worth roughly $32 billion and include controversial provisions, which we'll talk about. But the money could help a lot of people and communities struggling with addiction.
NPR's Brian Mann is our addiction correspondent, and he joins me this morning. Hey, Brian.
BRIAN MANN, BYLINE8: Hey. Good morning, Rachel.
MARTIN: Thirty-two billion dollars - I mean, that's objectively a lot of money. What kind of difference can it make, though?
MANN: Well, yeah. I think this is a game changer. Under the deals being finalized, the way they're structured, this money would be paid out over time over the next couple decades. So that means a new steady stream of funding for things like drug treatment and harm reduction programs. And that's going to save lives at a time when drug overdoses are continuing to kill record numbers of Americans. These numbers just keep rising. The sad part is, it's important to say, that experts tell me this is not nearly enough money. Thirty-two billion sounds like a lot, but it's a fraction of the cost of tackling the opioid epidemic. Taxpayers9 already carrying most of the burden here, paying for rehab programs, foster care and law enforcement. And that's not going to change because of these settlements.
MARTIN: Just remind us what these companies are accused of.
MANN: So opioid medications became big business - OxyContin, but lots of other types of opioids as well. And so drug-makers like Purdue Pharma, Johnson & Johnson and then drug wholesalers like Cardinal10 Health and McKesson made huge profits selling these products. They're accused of pushing the use of these highly addictive11 pain pills more aggressively than made medical sense, even as addiction rates rose. And they're also accused of not having enough safeguards in place to keep these products from being abused or diverted for sale on the street on black markets. It's important to say, in all of this, the companies deny any wrongdoing.
MARTIN: And which companies are close to deals right now?
MANN: So let's talk about two major deals that appear close to the finish line. One involves Purdue Pharma and its owners, members of the Sackler family. You'll remember they reached a deal last year worth about $4.5 billion, but a federal judge threw that out. Too many states and the U.S. Justice Department objected to a provision granting the Sackler immunity12 from future lawsuits13. So closed-door talks quickly got underway again to try to get everyone on board with a new deal. And the big news now is the mediator14 is saying publicly the Sacklers have sweetened their offer. They're offering a total payout of roughly $6 billion. The mediator says there's been significant progress getting everyone on board, but they're not quite there yet.
MARTIN: So the Sacklers are offering more money. But have they changed their position on insisting that they be protected from future opioid lawsuits?
MANN: No. The Sacklers haven't budged15 from that demand, and that's why they need to get everybody on board. If this deal is finalized, they'll be sheltered from any future opioid lawsuits. We'll see if they get all the states to agree to that. One interesting development, Rachel, is that there are now growing calls, including from a group of U.S. senators - bipartisan senators - calling for criminal investigations16 into the Sacklers' role here. So far, no state or federal prosecutor17 has taken on that fight. And here again, important to say, the Sacklers deny any wrongdoing.
MARTIN: So that's Purdue Pharma. You said there were two major opioid deals close to being finalized. What's the second one?
MANN: Yeah. The other, actually, I expect to come sooner and to be bigger. Three huge drug distributors, AmerisourceBergen and Cardinal Health and McKesson, along with Johnson & Johnson, have agreed in principle to pay roughly $26 billion to settle opioid claims. That deal could come as early as Friday.
MARTIN: And there are still civil trials involving pharmacies18, right?
MANN: Yeah, that's right - Walmart, CVS, Walgreens. A lot more of this litigation still to come. So while these settlements are big, the sort of resolution of this opioid crisis in courts will go on.
MARTIN: NPR addiction correspondent Brian Mann - thank you so much, Brian.
MANN: Thank you, Rachel.
1 corporate | |
adj.共同的,全体的;公司的,企业的 | |
参考例句: |
|
|
2 finalized | |
vt.完成(finalize的过去式与过去分词形式) | |
参考例句: |
|
|
3 transcript | |
n.抄本,誊本,副本,肄业证书 | |
参考例句: |
|
|
4 embroiled | |
adj.卷入的;纠缠不清的 | |
参考例句: |
|
|
5 finalizing | |
vt.完成(finalize的现在分词形式) | |
参考例句: |
|
|
6 addiction | |
n.上瘾入迷,嗜好 | |
参考例句: |
|
|
7 epidemic | |
n.流行病;盛行;adj.流行性的,流传极广的 | |
参考例句: |
|
|
8 byline | |
n.署名;v.署名 | |
参考例句: |
|
|
9 taxpayers | |
纳税人,纳税的机构( taxpayer的名词复数 ) | |
参考例句: |
|
|
10 cardinal | |
n.(天主教的)红衣主教;adj.首要的,基本的 | |
参考例句: |
|
|
11 addictive | |
adj.(吸毒等)使成瘾的,成为习惯的 | |
参考例句: |
|
|
12 immunity | |
n.优惠;免除;豁免,豁免权 | |
参考例句: |
|
|
13 lawsuits | |
n.诉讼( lawsuit的名词复数 ) | |
参考例句: |
|
|
14 mediator | |
n.调解人,中介人 | |
参考例句: |
|
|
15 budged | |
v.(使)稍微移动( budge的过去式和过去分词 );(使)改变主意,(使)让步 | |
参考例句: |
|
|
16 investigations | |
(正式的)调查( investigation的名词复数 ); 侦查; 科学研究; 学术研究 | |
参考例句: |
|
|
17 prosecutor | |
n.起诉人;检察官,公诉人 | |
参考例句: |
|
|
18 pharmacies | |
药店 | |
参考例句: |
|
|